These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 3459390)
1. Imipenem coadministered with cilastatin compared with moxalactam: integration of serum pharmacokinetics and microbiologic activity following single-dose administration to normal volunteers. Standiford HC; Drusano GL; Bustamante CI; Rivera G; Forrest A; Tatem B; Leslie J; Moody M Antimicrob Agents Chemother; 1986 Mar; 29(3):412-7. PubMed ID: 3459390 [TBL] [Abstract][Full Text] [Related]
2. A multiclinic randomized study of the comparative efficacy, safety and tolerance of imipenem/cilastatin and moxalactam. Calandra GB; Hesney M; Grad C Eur J Clin Microbiol; 1984 Oct; 3(5):478-87. PubMed ID: 6389126 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the pharmacokinetics of ceftazidime and moxalactam and their microbiological correlates in volunteers. Drusano GL; Standiford HC; Fitzpatrick B; Leslie J; Tangtatsawasdi P; Ryan P; Tatem B; Moody MR; Schimpff SC Antimicrob Agents Chemother; 1984 Sep; 26(3):388-93. PubMed ID: 6391372 [TBL] [Abstract][Full Text] [Related]
4. Serum bactericidal activities and comparative pharmacokinetics of meropenem and imipenem-cilastatin. Dreetz M; Hamacher J; Eller J; Borner K; Koeppe P; Schaberg T; Lode H Antimicrob Agents Chemother; 1996 Jan; 40(1):105-9. PubMed ID: 8787889 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic profile of imipenem/cilastatin in normal volunteers. Drusano GL; Standiford HC Am J Med; 1985 Jun; 78(6A):47-53. PubMed ID: 3859215 [TBL] [Abstract][Full Text] [Related]
6. [Fundamental and clinical studies on imipenem/cilastatin sodium in the pediatric field]. Toyonaga Y; Sugita M; Tsuda T; Takahashi T; Hori M Jpn J Antibiot; 1986 Jul; 39(7):1765-86. PubMed ID: 3464778 [TBL] [Abstract][Full Text] [Related]
8. [Fundamental and clinical studies on imipenem/cilastatin sodium in pediatrics]. Shiro H; Kusumoto Y; Oikawa T; Osano M Jpn J Antibiot; 1986 Jul; 39(7):1787-803. PubMed ID: 3464779 [TBL] [Abstract][Full Text] [Related]
9. [Clinical laboratory approach to estimating the effective administration dose of imipenem/cilastatin. Evaluation of the disk susceptibility test and its interpretation system]. Matsuo K; Uete T Jpn J Antibiot; 1989 Nov; 42(11):2377-92. PubMed ID: 2621780 [TBL] [Abstract][Full Text] [Related]
10. [Fundamental and clinical studies of imipenem/cilastatin sodium in the field of obstetrics and gynecology. Study group of imipenem/cilastatin sodium in the field of obstetric and gynecological infections]. Matsuda S; Suzuki M; Hasegawa Y; Ninomiya K; Shimizu T; Maeda Y; Ichinoe K; Makinoda S; Sato H; Sato H Jpn J Antibiot; 1986 Jun; 39(6):1626-55. PubMed ID: 3531568 [TBL] [Abstract][Full Text] [Related]